Similar articles

• [Role of immunotherapy in the combined treatment of lung cancer].

  Trapeznikov NN, Gorodilova VV, Babakova SV, Kadagidze ZG, Trakhtenberg AKh. Trapeznikov NN, et al. Vopr Onkol. 1982;28(2):51-6. Vopr Onkol. 1982. PMID: 6278769 Clinical Trial. Russian. No abstract available.
• Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.

  Mikulski SM, McGuire WP, Louie AC, Chirigos MA, Muggia FM. Mikulski SM, et al. Cancer Treat Rev. 1979 Sep;6(3):177-90. doi: 10.1016/s0305-7372(79)80069-9. Cancer Treat Rev. 1979. PMID: 394836 Review. No abstract available.
• Perspectives in immunotherapy of lung cancer.

  Hersh EM, Gutterman JU, Mavligit GM. Hersh EM, et al. Cancer Treat Rev. 1974 Mar;1(1):65-80. doi: 10.1016/s0305-7372(74)80011-3. Cancer Treat Rev. 1974. PMID: 4471091 No abstract available.
• Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).

  Jansen HM, The TH, de Gast GC, Esselink MT, van der Wal AM, Orie NG. Jansen HM, et al. Thorax. 1978 Aug;33(4):429-38. doi: 10.1136/thx.33.4.429. Thorax. 1978. PMID: 358479 Free PMC article. Clinical Trial.
• [Immunotherapy of carcinoma of the lung].

  Sega E, Mineo TC, Rea SR, Sega FM Jr, Ricci C. Sega E, et al. Recenti Prog Med. 1978 Mar;64(3):293-309. Recenti Prog Med. 1978. PMID: 351751 Review. Italian. No abstract available.